| pubmed-article:8646440 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C0029921 | lld:lifeskim |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C1947933 | lld:lifeskim |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C0242479 | lld:lifeskim |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C0206034 | lld:lifeskim |
| pubmed-article:8646440 | lifeskim:mentions | umls-concept:C0205547 | lld:lifeskim |
| pubmed-article:8646440 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8646440 | pubmed:dateCreated | 1996-7-19 | lld:pubmed |
| pubmed-article:8646440 | pubmed:abstractText | The aim of the present study was to compare the effects of in-patient multidisciplinary treatment with standard out-patient care in patients with active rheumatoid arthritis (RA). Eighty patients with active RA were randomized to receive 11 days of in-patient multidisciplinary treatment followed by standard out-patient care (n = 39), or to standard out-patient care only (n = 41). Patients were assessed at baseline, and after 2, 4, 12 and 52 weeks. In the in-patients, the improvement in variables of disease activity (weeks 2 and 4) and emotional status (weeks 4 and 12) was greater when compared with the out-patients (P < 0.05). The improvement in laboratory and functional measures did not differ between the groups. In the in-patient group, the percentage of patients responding to the American College of Rheumatology criteria for improvement was significantly greater at any time point during follow-up than in the out-patient group. A short period of in-patient multidisciplinary treatment for active RA has a direct beneficial effect on disease activity and emotional status with the favourable effect on disease activity remaining after 52 weeks. | lld:pubmed |
| pubmed-article:8646440 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8646440 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8646440 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8646440 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8646440 | pubmed:month | May | lld:pubmed |
| pubmed-article:8646440 | pubmed:issn | 0263-7103 | lld:pubmed |
| pubmed-article:8646440 | pubmed:author | pubmed-author:HazelJ FJF | lld:pubmed |
| pubmed-article:8646440 | pubmed:author | pubmed-author:BreedveldF... | lld:pubmed |
| pubmed-article:8646440 | pubmed:author | pubmed-author:Vandenbroucke... | lld:pubmed |
| pubmed-article:8646440 | pubmed:author | pubmed-author:ZwindermanA... | lld:pubmed |
| pubmed-article:8646440 | pubmed:author | pubmed-author:Vliet... | lld:pubmed |
| pubmed-article:8646440 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8646440 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:8646440 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8646440 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8646440 | pubmed:pagination | 475-82 | lld:pubmed |
| pubmed-article:8646440 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:meshHeading | pubmed-meshheading:8646440-... | lld:pubmed |
| pubmed-article:8646440 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8646440 | pubmed:articleTitle | A randomized clinical trial of in-patient multidisciplinary treatment versus routine out-patient care in active rheumatoid arthritis. | lld:pubmed |
| pubmed-article:8646440 | pubmed:affiliation | Department of Rheumatology, University Hospital Leiden, The Netherlands. | lld:pubmed |
| pubmed-article:8646440 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8646440 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8646440 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8646440 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8646440 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8646440 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8646440 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8646440 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8646440 | lld:pubmed |
